| COMPOSITION | GLIMEPRIDE...1MG,METFORMIN...500MG(SR),VOGLIBOSE...0.2MG |
| Packing | 10X10,10X15 |
| Uses | Delays progression of atherosclerosis, Reduces hepatic glucose production, Antidiabetic with least risk of hypoglycemia |
| Indication | TYPE-II DIABETES MELLITUS, POSTPRANDIAL DIABETES MELLITUS |
| Key Ingrediants | GLIMEPIRIDE 1MG,METFORMIN 500MG(SR),VOGLIBOSE 0.2MG TABLET |
| PRODUCT DISCRIPTION | It's a combination pill that is composed of Glimepiride 1 mg, Metformin 500 mg (sustained release), and Voglibose 0.2 mg which is used to treat type 2 diabetes. Hence this combination uses the complimentary modes of action of the three medications to improve glycemic control. |